PAPA JOSEPH C
Insider CIK 1242215 · EBS President and CEO, Director · MIST Director · PRGO President and CEO, Director · RXDX Director · CADL Director · BLCO CEO & Chairman, Director · PRGO President and CEO, Director · VRX Chairman and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CADL Candel Therapeutics, Inc. | A Award deriv | 2026-09-30 | 2026-10-02 | 1,325 | $8.68 | $11.5K | 1,325 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award deriv | 2026-06-30 | 2026-07-01 | 1,331 | $8.64 | $11.5K | 1,331 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award deriv | 2026-06-23 | 2026-06-24 | 32,000 | — | $0 | 32,000 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2026-06-10 | 2026-06-12 | 77,000 | — | $0 | 77,000 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2026-04-29 | 2026-05-01 | 187,708 | — | $0 | 493,153 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award deriv | 2026-03-31 | 2026-04-02 | 2,795 | $4.11 | $11.5K | 2,795 | SEC↗ |
| EBS Emergent BioSolutions Inc. | F Tax w/h | 2026-03-05 | 2026-03-05 | 37,055 | $8.44 | $312.7K | 305,445 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2026-03-03 | 2026-03-05 | 252,194 | — | $0 | 1,784,694 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2025-07-11 | 2025-07-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2025-07-11 | 2025-07-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award | 2025-07-11 | 2025-07-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award | 2025-06-25 | 2025-06-26 | 64,239 | $4.67 | $300.0K | 64,239 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award deriv | 2025-06-17 | 2025-06-18 | 14,240 | — | $0 | 14,240 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2025-06-10 | 2025-06-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EBS Emergent BioSolutions Inc. | P Buy | 2025-05-13 | 2025-05-15 | 60,000 | $5.83 | $349.8K | 342,500 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2025-03-12 | 2025-03-12 | 250,000 | — | $0 | 1,282,500 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2025-03-12 | 2025-03-12 | 250,000 | — | $0 | 1,532,500 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2025-03-06 | 2025-03-10 | 282,500 | — | $0 | 1,032,500 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award | 2025-03-06 | 2025-03-10 | 282,500 | — | $0 | 282,500 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2024-09-03 | 2024-09-05 | 80,000 | — | $0 | 80,000 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award deriv | 2024-06-26 | 2024-06-27 | 14,240 | — | $0 | 14,240 | SEC↗ |
| EBS Emergent BioSolutions Inc. | A Award deriv | 2024-03-13 | 2024-03-15 | 750,000 | — | $0 | 750,000 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award deriv | 2023-06-28 | 2023-06-29 | 14,240 | — | $0 | 14,240 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer deriv | 2023-06-16 | 2023-06-16 | 27,340 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer deriv | 2023-06-16 | 2023-06-16 | 15,000 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer deriv | 2023-06-16 | 2023-06-16 | 22,652 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer deriv | 2023-06-16 | 2023-06-16 | 2,165 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer deriv | 2023-06-16 | 2023-06-16 | 22,551 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer | 2023-06-16 | 2023-06-16 | 10,000 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | D To issuer | 2023-06-16 | 2023-06-16 | 7,278 | — | $0 | 0 | SEC↗ |
| RXDX Prometheus Biosciences, In | J Other | 2023-06-02 | 2023-06-02 | 10,000 | — | $0 | 7,278 | SEC↗ |
| RXDX Prometheus Biosciences, In | J Other | 2023-06-02 | 2023-06-02 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RXDX Prometheus Biosciences, In | A Award | 2023-05-19 | 2023-05-19 | 2,278 | — | $0 | 17,278 | SEC↗ |
| CADL Candel Therapeutics, Inc. | P Buy | 2022-12-09 | 2022-12-12 | 35,018 | $1.94 | $67.9K | 38,032 | SEC↗ |
| CADL Candel Therapeutics, Inc. | P Buy | 2022-12-08 | 2022-12-12 | 3,014 | $1.70 | $5.1K | 3,014 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award deriv | 2022-08-08 | 2022-08-10 | 28,480 | — | $0 | 28,480 | SEC↗ |
| RXDX Prometheus Biosciences, In | A Award deriv | 2022-05-19 | 2022-05-20 | 22,551 | — | $0 | 22,551 | SEC↗ |
| BHC Bausch Health Companies In | A Award deriv | 2022-05-10 | 2022-05-12 | 65,911 | — | $0 | 0 | SEC↗ |
| BHC Bausch Health Companies In | M Exercise deriv | 2022-05-10 | 2022-05-12 | 65,911 | $9.40 | $619.6K | 0 | SEC↗ |
| BHC Bausch Health Companies In | M Exercise deriv | 2022-05-10 | 2022-05-12 | 183,522 | $9.40 | $1.73M | 0 | SEC↗ |
| BHC Bausch Health Companies In | A Award deriv | 2022-05-10 | 2022-05-12 | 183,522 | — | $0 | 0 | SEC↗ |
| BHC Bausch Health Companies In | M Exercise deriv | 2022-05-10 | 2022-05-12 | 116,697 | $9.40 | $1.10M | 0 | SEC↗ |
| BHC Bausch Health Companies In | A Award deriv | 2022-05-10 | 2022-05-12 | 116,697 | — | $0 | 0 | SEC↗ |
| BHC Bausch Health Companies In | M Exercise | 2022-05-10 | 2022-05-12 | 116,697 | — | $0 | 1,211,849 | SEC↗ |
| BHC Bausch Health Companies In | M Exercise | 2022-05-10 | 2022-05-12 | 183,522 | — | $0 | 1,395,371 | SEC↗ |
| BHC Bausch Health Companies In | M Exercise | 2022-05-10 | 2022-05-12 | 65,911 | — | $0 | 1,461,282 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2022-05-10 | 2022-05-12 | 33,714 | $9.40 | $316.9K | 1,427,568 | SEC↗ |
| BLCO Bausch & Lomb Corp | A Award deriv | 2022-05-05 | 2022-05-09 | 1,868,131 | — | $0 | 1,868,131 | SEC↗ |
| BLCO Bausch & Lomb Corp | A Award | 2022-05-05 | 2022-05-09 | 472,222 | — | $0 | 472,222 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2022-03-03 | 2022-03-07 | 12,643 | $23.61 | $298.5K | 1,095,152 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2022-02-28 | 2022-03-02 | 5,115 | $24.06 | $123.1K | 1,107,795 | SEC↗ |
| BHC Bausch Health Companies In | A Award deriv | 2022-02-27 | 2022-03-02 | 208,231 | — | $0 | 0 | SEC↗ |
| BHC Bausch Health Companies In | M Exercise deriv | 2022-02-27 | 2022-03-02 | 208,231 | $24.35 | $5.07M | 0 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2022-02-27 | 2022-03-02 | 13,206 | $24.35 | $321.6K | 1,112,910 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2022-02-27 | 2022-03-02 | 100,351 | $24.35 | $2.44M | 1,139,299 | SEC↗ |
| BHC Bausch Health Companies In | M Exercise | 2022-02-27 | 2022-03-02 | 208,231 | — | $0 | 1,239,650 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2022-02-26 | 2022-03-02 | 13,183 | $24.35 | $321.0K | 1,126,116 | SEC↗ |
| RXDX Prometheus Biosciences, In | A Award deriv | 2021-11-14 | 2021-11-16 | 2,165 | — | $0 | 2,165 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2021-09-14 | 2021-09-15 | 5,010 | $28.66 | $143.6K | 1,031,419 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2021-09-13 | 2021-09-15 | 3,549 | $29.19 | $103.6K | 1,036,429 | SEC↗ |
| RXDX Prometheus Biosciences, In | P Buy | 2021-03-16 | 2021-03-16 | 15,000 | $19.00 | $285.0K | 15,000 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2021-03-10 | 2021-03-10 | 231,188 | $32.97 | $7.62M | 1,039,978 | SEC↗ |
| BHC Bausch Health Companies In | M Exercise deriv | 2021-03-08 | 2021-03-10 | 317,089 | — | $0 | 0 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2021-03-08 | 2021-03-10 | 108,254 | — | $0 | 1,271,166 | SEC↗ |
| BHC Bausch Health Companies In | M Exercise | 2021-03-08 | 2021-03-10 | 317,089 | — | $0 | 1,162,912 | SEC↗ |
| BHC Bausch Health Companies In | A Award deriv | 2021-03-03 | 2021-03-05 | 196,464 | — | $0 | 196,464 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2021-03-03 | 2021-03-05 | 74,150 | — | $0 | 845,823 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2021-03-01 | 2021-03-03 | 28,192 | $31.42 | $885.8K | 771,673 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2020-09-15 | 2020-09-16 | 5,115 | $15.91 | $81.4K | 799,865 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2020-09-14 | 2020-09-16 | 3,623 | $15.40 | $55.8K | 804,980 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2020-05-04 | 2020-05-06 | 95,489 | $17.16 | $1.64M | 808,603 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2020-03-09 | 2020-03-11 | 18,488 | $20.96 | $387.5K | 904,092 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2020-03-02 | 2020-03-03 | 4,925 | $22.52 | $110.9K | 922,580 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2020-02-28 | 2020-03-03 | 9,269 | $24.44 | $226.5K | 927,505 | SEC↗ |
| BHC Bausch Health Companies In | A Award deriv | 2020-02-26 | 2020-02-28 | 341,114 | — | $0 | 341,114 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2020-02-26 | 2020-02-28 | 81,040 | — | $0 | 936,774 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2019-09-16 | 2019-09-18 | 5,115 | $23.24 | $118.9K | 855,734 | SEC↗ |
| BHC Bausch Health Companies In | P Buy | 2019-09-13 | 2019-09-13 | 30,000 | $23.31 | $699.3K | 839,601 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2019-09-13 | 2019-09-13 | 21,248 | — | $0 | 860,849 | SEC↗ |
| BHC Bausch Health Companies In | F Tax w/h | 2019-03-08 | 2019-03-12 | 18,658 | $23.56 | $439.6K | 809,601 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2019-02-28 | 2019-02-28 | 30,000 | — | $0 | 747,077 | SEC↗ |
| BHC Bausch Health Companies In | P Buy | 2019-02-28 | 2019-02-28 | 30,000 | $23.67 | $710.1K | 717,077 | SEC↗ |
| BHC Bausch Health Companies In | A Award deriv | 2019-02-27 | 2019-03-01 | 236,183 | — | $0 | 236,183 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2019-02-27 | 2019-03-01 | 81,182 | — | $0 | 768,259 | SEC↗ |
| BHC Bausch Health Companies In | P Buy | 2018-09-14 | 2018-09-17 | 30,000 | $22.32 | $669.6K | 657,077 | SEC↗ |
| BHC Bausch Health Companies In | A Award | 2018-09-14 | 2018-09-17 | 30,000 | — | $0 | 687,077 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2018-05-03 | 2018-05-04 | 91,942 | $18.31 | $1.68M | 627,077 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2018-03-13 | 2018-03-13 | 30,000 | $16.05 | $481.5K | 719,019 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award deriv | 2018-03-07 | 2018-03-09 | 511,434 | — | $0 | 511,434 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award deriv | 2018-03-07 | 2018-03-09 | 338,058 | — | $0 | 338,058 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2018-03-07 | 2018-03-09 | 113,652 | — | $0 | 689,019 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2016-06-10 | 2016-06-13 | 202,000 | $24.48 | $4.94M | 2,442,199 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award deriv | 2016-06-09 | 2016-06-13 | 682,652 | — | $0 | 682,652 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2016-05-02 | 2016-05-04 | 2,240,199 | — | $0 | 2,240,199 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2016-02-26 | 2016-03-01 | 74,166 | $129.23 | $9.58M | 74,166 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2016-02-26 | 2016-03-01 | 13,077 | — | $0 | 13,077 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2015-12-28 | 2015-12-30 | 10,285 | — | $0 | 10,285 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2015-12-28 | 2015-12-30 | 10,183 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | S Sale | 2015-12-28 | 2015-12-30 | 1,560 | $147.49 | $230.1K | 119,415 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2015-12-28 | 2015-12-30 | 10,183 | $58.82 | $599.0K | 129,598 | SEC↗ |
| PRGO PERRIGO Co plc | S Sale | 2015-12-28 | 2015-12-30 | 8,623 | $146.99 | $1.27M | 120,975 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2015-08-21 | 2015-08-25 | 7,365 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2015-08-21 | 2015-08-25 | 7,365 | $186.89 | $1.38M | 123,234 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2015-08-21 | 2015-08-25 | 8,555 | $186.89 | $1.60M | 115,869 | SEC↗ |
| PRGO PERRIGO Co plc | A Award | 2015-08-21 | 2015-08-25 | 16,499 | $186.89 | $3.08M | 124,424 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2015-08-21 | 2015-08-25 | 3,819 | $186.89 | $713.7K | 119,415 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2015-06-29 | 2015-07-01 | 21,994 | — | $0 | 21,994 | SEC↗ |
| PRGO PERRIGO Co plc | G Gift | 2015-03-13 | 2015-12-30 | 900 | — | $0 | 118,515 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2014-08-22 | 2014-08-26 | 11,419 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | A Award | 2014-08-22 | 2014-08-26 | 14,388 | $149.22 | $2.15M | 109,888 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2014-08-22 | 2014-08-26 | 5,921 | $149.22 | $883.5K | 107,925 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2014-08-22 | 2014-08-26 | 7,461 | $149.22 | $1.11M | 102,427 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2014-08-22 | 2014-08-26 | 11,419 | $149.22 | $1.70M | 113,846 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2014-08-21 | 2014-08-25 | 9,340 | — | $0 | 9,340 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2014-08-21 | 2014-08-25 | 50,611 | $147.75 | $7.48M | 50,611 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2014-08-21 | 2014-08-25 | 6,768 | — | $0 | 6,768 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2014-03-24 | 2014-03-26 | 10,000 | — | $0 | 10,183 | SEC↗ |
| PRGO PERRIGO Co plc | S Sale | 2014-03-24 | 2014-03-26 | 1,700 | $157.91 | $268.4K | 97,755 | SEC↗ |
| PRGO PERRIGO Co plc | S Sale | 2014-03-24 | 2014-03-26 | 6,045 | $157.00 | $949.1K | 99,455 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2014-03-24 | 2014-03-26 | 10,000 | $58.85 | $588.5K | 105,500 | SEC↗ |
| PRGO PERRIGO Co plc | S Sale | 2014-03-24 | 2014-03-26 | 1,000 | $159.07 | $159.1K | 96,755 | SEC↗ |
| PRGO PERRIGO Co plc | S Sale | 2014-03-24 | 2014-03-26 | 1,255 | $159.81 | $200.6K | 95,500 | SEC↗ |
| PRGO PERRIGO Co plc | G Gift | 2014-03-05 | 2014-03-26 | 1,155 | — | $0 | 95,500 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2014-02-14 | 2014-02-19 | 5,000 | — | $0 | 20,183 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2014-02-14 | 2014-02-19 | 5,000 | $58.82 | $294.1K | 101,655 | SEC↗ |
| PRGO PERRIGO Co plc | S Sale | 2014-02-14 | 2014-02-19 | 4,700 | $150.47 | $707.2K | 96,955 | SEC↗ |
| PRGO PERRIGO Co plc | S Sale | 2014-02-14 | 2014-02-19 | 300 | $151.06 | $45.3K | 96,655 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2014-01-16 | 2014-01-21 | 5,000 | — | $0 | 25,183 | SEC↗ |
| PRGO PERRIGO Co plc | S Sale | 2014-01-16 | 2014-01-21 | 300 | $157.04 | $47.1K | 101,355 | SEC↗ |
| PRGO PERRIGO Co plc | S Sale | 2014-01-16 | 2014-01-21 | 4,700 | $157.63 | $740.9K | 96,655 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2014-01-16 | 2014-01-21 | 5,000 | $58.82 | $294.1K | 101,655 | SEC↗ |
| PRGO PERRIGO CO | D To issuer deriv | 2013-12-18 | 2013-12-19 | 30,183 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO CO | D To issuer deriv | 2013-12-18 | 2013-12-19 | 44,843 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO CO | D To issuer deriv | 2013-12-18 | 2013-12-19 | 44,496 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO CO | D To issuer deriv | 2013-12-18 | 2013-12-19 | 46,293 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO CO | D To issuer deriv | 2013-12-18 | 2013-12-19 | 11,418 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO CO | D To issuer deriv | 2013-12-18 | 2013-12-19 | 9,517 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO CO | D To issuer deriv | 2013-12-18 | 2013-12-19 | 7,365 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2013-12-18 | 2013-12-20 | 30,183 | — | $0 | 30,183 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2013-12-18 | 2013-12-20 | 44,843 | — | $0 | 44,843 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2013-12-18 | 2013-12-20 | 44,496 | — | $0 | 44,496 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2013-12-18 | 2013-12-20 | 46,293 | — | $0 | 46,293 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2013-12-18 | 2013-12-20 | 11,419 | — | $0 | 11,419 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2013-12-18 | 2013-12-20 | 9,518 | — | $0 | 9,518 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2013-12-18 | 2013-12-20 | 7,365 | — | $0 | 7,365 | SEC↗ |
| PRGO PERRIGO CO | D To issuer | 2013-12-18 | 2013-12-19 | 96,655 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | A Award | 2013-12-18 | 2013-12-20 | 96,655 | — | $0 | 96,655 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2013-12-12 | 2013-12-16 | 2,186 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2013-12-12 | 2013-12-16 | 8,851 | — | $0 | 30,183 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2013-12-12 | 2013-12-16 | 3,963 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2013-12-12 | 2013-12-16 | 7,687 | $150.07 | $1.15M | 116,655 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2013-12-12 | 2013-12-16 | 1,164 | $149.43 | $173.9K | 124,342 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2013-12-12 | 2013-12-16 | 8,851 | $58.82 | $520.6K | 125,506 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2013-12-12 | 2013-12-16 | 2,186 | $30.06 | $65.7K | 118,841 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2013-12-12 | 2013-12-16 | 3,963 | $150.22 | $595.3K | 116,655 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2013-12-12 | 2013-12-16 | 3,963 | $35.85 | $142.1K | 120,618 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2013-12-12 | 2013-12-16 | 2,186 | $150.49 | $329.0K | 116,655 | SEC↗ |
| PRGO PERRIGO CO | G Gift | 2013-12-09 | 2013-12-16 | 20,000 | — | $0 | 96,655 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2013-09-24 | 2013-09-26 | 15,000 | — | $0 | 3,963 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2013-09-24 | 2013-09-26 | 15,000 | $35.85 | $537.8K | 131,655 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2013-09-24 | 2013-09-26 | 15,000 | $124.60 | $1.87M | 116,655 | SEC↗ |
| PRGO PERRIGO CO | G Gift | 2013-09-05 | 2013-09-13 | 450 | — | $0 | 116,655 | SEC↗ |
| PRGO PERRIGO CO | G Gift | 2013-09-03 | 2013-09-13 | 1,350 | — | $0 | 117,105 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2013-08-27 | 2013-08-29 | 15,000 | — | $0 | 18,963 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2013-08-27 | 2013-08-29 | 15,000 | $35.85 | $537.8K | 133,455 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2013-08-27 | 2013-08-29 | 15,000 | $117.64 | $1.76M | 118,455 | SEC↗ |
| PRGO PERRIGO CO | A Award | 2013-08-23 | 2013-08-26 | 19,259 | $119.38 | $2.30M | 127,353 | SEC↗ |
| PRGO PERRIGO CO | F Tax w/h | 2013-08-23 | 2013-08-26 | 8,898 | $119.38 | $1.06M | 118,455 | SEC↗ |
| PRGO PERRIGO CO | A Award deriv | 2013-08-22 | 2013-08-26 | 9,517 | — | $0 | 9,517 | SEC↗ |
| PRGO PERRIGO CO | A Award deriv | 2013-08-22 | 2013-08-26 | 44,496 | $119.78 | $5.33M | 44,496 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2013-08-19 | 2013-08-21 | 15,046 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO CO | F Tax w/h | 2013-08-19 | 2013-08-21 | 6,952 | $118.74 | $825.5K | 108,094 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2013-08-19 | 2013-08-21 | 15,046 | $118.74 | $1.79M | 115,046 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2013-07-11 | 2013-07-15 | 10,000 | — | $0 | 33,963 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2013-07-11 | 2013-07-15 | 8,000 | $128.44 | $1.03M | 102,000 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2013-07-11 | 2013-07-15 | 2,000 | $128.93 | $257.9K | 100,000 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2013-07-11 | 2013-07-15 | 10,000 | $35.85 | $358.5K | 110,000 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2013-06-14 | 2013-06-18 | 10,000 | — | $0 | 43,963 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2013-06-14 | 2013-06-18 | 8,095 | $118.31 | $957.7K | 101,905 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2013-06-14 | 2013-06-18 | 1,905 | $118.75 | $226.2K | 100,000 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2013-06-14 | 2013-06-18 | 10,000 | $35.85 | $358.5K | 110,000 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2013-05-15 | 2013-05-17 | 5,000 | — | $0 | 53,963 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2013-05-15 | 2013-05-17 | 1,200 | $121.00 | $145.2K | 100,000 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2013-05-15 | 2013-05-17 | 5,000 | $35.85 | $179.3K | 105,000 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2013-05-15 | 2013-05-17 | 3,800 | $120.36 | $457.4K | 101,200 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2013-04-09 | 2013-04-11 | 5,000 | — | $0 | 2,186 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2013-04-09 | 2013-04-11 | 5,000 | $118.29 | $591.5K | 105,645 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2013-04-09 | 2013-04-11 | 5,645 | $118.62 | $669.6K | 100,000 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2013-04-09 | 2013-04-11 | 5,000 | $30.06 | $150.3K | 110,645 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2013-03-12 | 2013-03-14 | 5,000 | — | $0 | 7,186 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2013-03-12 | 2013-03-14 | 2,000 | $117.50 | $235.0K | 105,645 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2013-03-12 | 2013-03-14 | 10,000 | $116.09 | $1.16M | 105,645 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2013-03-12 | 2013-03-14 | 5,000 | $30.06 | $150.3K | 110,645 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2013-03-12 | 2013-03-14 | 3,000 | $116.33 | $349.0K | 107,645 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2013-02-14 | 2013-02-19 | 5,000 | — | $0 | 12,186 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2013-02-14 | 2013-02-19 | 5,000 | $112.07 | $560.4K | 115,645 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2013-02-14 | 2013-02-19 | 5,000 | $30.06 | $150.3K | 120,645 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2013-01-17 | 2013-01-22 | 5,000 | — | $0 | 17,186 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2013-01-17 | 2013-01-22 | 5,000 | $104.50 | $522.5K | 115,645 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2013-01-17 | 2013-01-22 | 5,000 | $30.06 | $150.3K | 120,645 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2012-12-14 | 2012-12-18 | 1,607 | — | $0 | 22,186 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2012-12-14 | 2012-12-18 | 2,587 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2012-12-14 | 2012-12-18 | 10,806 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2012-12-14 | 2012-12-18 | 4,194 | $104.15 | $436.8K | 115,645 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2012-12-14 | 2012-12-18 | 10,806 | $103.86 | $1.12M | 119,839 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2012-12-14 | 2012-12-18 | 4,194 | $30.06 | $126.1K | 130,645 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2012-12-14 | 2012-12-18 | 10,806 | $20.50 | $221.5K | 126,451 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2012-11-15 | 2012-11-19 | 15,000 | — | $0 | 2,587 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2012-11-15 | 2012-11-19 | 14,200 | $100.75 | $1.43M | 116,445 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2012-11-15 | 2012-11-19 | 800 | $101.28 | $81.0K | 115,645 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2012-11-15 | 2012-11-19 | 15,000 | $30.06 | $450.9K | 130,645 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2012-10-10 | 2012-10-12 | 8,794 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2012-10-10 | 2012-10-12 | 6,206 | — | $0 | 17,587 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2012-10-10 | 2012-10-12 | 11,950 | $117.23 | $1.40M | 118,695 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2012-10-10 | 2012-10-12 | 3,050 | $117.93 | $359.7K | 115,645 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2012-10-10 | 2012-10-12 | 15,000 | $30.06 | $450.9K | 130,645 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2012-09-21 | 2012-09-25 | 15,000 | — | $0 | 8,794 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2012-09-21 | 2012-09-25 | 13,595 | $116.68 | $1.59M | 115,645 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2012-09-21 | 2012-09-25 | 1,405 | $115.72 | $162.6K | 129,240 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2012-09-21 | 2012-09-25 | 15,000 | $30.06 | $450.9K | 130,645 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2012-08-30 | 2012-09-04 | 10,000 | — | $0 | 10,806 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2012-08-30 | 2012-09-04 | 2,640 | $109.55 | $289.2K | 115,645 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2012-08-30 | 2012-09-04 | 7,360 | $109.04 | $802.5K | 118,285 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2012-08-30 | 2012-09-04 | 10,000 | $20.50 | $205.0K | 125,645 | SEC↗ |
| PRGO PERRIGO CO | G Gift | 2012-08-29 | 2012-09-04 | 24,200 | — | $0 | 115,645 | SEC↗ |
| PRGO PERRIGO CO | G Gift | 2012-08-28 | 2012-09-04 | 1,800 | — | $0 | 139,845 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2012-08-27 | 2012-08-29 | 26,447 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2012-08-27 | 2012-08-29 | 43,902 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2012-08-27 | 2012-08-29 | 43,902 | $110.66 | $4.86M | 143,902 | SEC↗ |
| PRGO PERRIGO CO | F Tax w/h | 2012-08-27 | 2012-08-29 | 17,913 | $110.66 | $1.98M | 125,985 | SEC↗ |
| PRGO PERRIGO CO | F Tax w/h | 2012-08-27 | 2012-08-29 | 10,791 | $110.66 | $1.19M | 141,645 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2012-08-27 | 2012-08-29 | 26,447 | $110.66 | $2.93M | 152,432 | SEC↗ |
| PRGO PERRIGO CO | A Award deriv | 2012-08-23 | 2012-08-27 | 14,948 | — | $0 | 14,948 | SEC↗ |
| PRGO PERRIGO CO | A Award deriv | 2012-08-23 | 2012-08-27 | 14,947 | — | $0 | 14,947 | SEC↗ |
| PRGO PERRIGO CO | A Award deriv | 2012-08-23 | 2012-08-27 | 7,365 | — | $0 | 7,365 | SEC↗ |
| PRGO PERRIGO CO | A Award deriv | 2012-08-23 | 2012-08-27 | 14,948 | — | $0 | 14,948 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2012-07-18 | 2012-07-20 | 1,563 | — | $0 | 18,613 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2012-07-18 | 2012-07-20 | 8,437 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2012-07-18 | 2012-07-20 | 8,437 | $20.50 | $173.0K | 108,437 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2012-07-18 | 2012-07-20 | 1,500 | $114.06 | $171.1K | 106,937 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2012-07-18 | 2012-07-20 | 6,937 | $115.13 | $798.7K | 100,000 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2012-07-18 | 2012-07-20 | 1,563 | $35.85 | $56.0K | 101,563 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2012-07-18 | 2012-07-20 | 300 | $114.14 | $34.2K | 101,263 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2012-07-18 | 2012-07-20 | 1,263 | $115.16 | $145.4K | 100,000 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2012-06-20 | 2012-06-22 | 10,000 | — | $0 | 8,437 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2012-06-20 | 2012-06-22 | 10,000 | $114.92 | $1.15M | 100,000 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2012-06-20 | 2012-06-22 | 10,000 | $20.50 | $205.0K | 110,000 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2012-05-21 | 2012-05-23 | 2,369 | — | $0 | 18,437 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2012-05-21 | 2012-05-23 | 2,631 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2012-05-21 | 2012-05-23 | 10,912 | $99.22 | $1.08M | 100,000 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2012-05-21 | 2012-05-23 | 5,000 | $20.50 | $102.5K | 105,000 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2012-05-21 | 2012-05-23 | 5,000 | $99.23 | $496.1K | 100,000 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2012-04-19 | 2012-04-23 | 5,000 | — | $0 | 2,631 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2012-04-19 | 2012-04-23 | 5,000 | $20.50 | $102.5K | 115,912 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2012-04-19 | 2012-04-23 | 5,000 | $106.59 | $533.0K | 110,912 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2012-03-22 | 2012-03-26 | 5,000 | — | $0 | 7,631 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2012-03-22 | 2012-03-26 | 5,000 | $102.25 | $511.3K | 110,912 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2012-03-22 | 2012-03-26 | 5,000 | $20.50 | $102.5K | 115,912 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2012-02-22 | 2012-02-24 | 2,958 | — | $0 | 12,631 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2012-02-22 | 2012-02-24 | 2,042 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2012-02-22 | 2012-02-24 | 2,958 | $93.73 | $277.3K | 110,912 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2012-02-22 | 2012-02-24 | 2,958 | $20.58 | $60.9K | 113,870 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2012-02-22 | 2012-02-24 | 2,042 | $93.72 | $191.4K | 110,912 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2012-02-22 | 2012-02-24 | 2,042 | $17.29 | $35.3K | 112,954 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2012-01-19 | 2012-01-23 | 5,000 | — | $0 | 2,042 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2012-01-19 | 2012-01-23 | 5,000 | $99.98 | $499.9K | 110,912 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2012-01-19 | 2012-01-23 | 5,000 | $17.29 | $86.5K | 115,912 | SEC↗ |
| PRGO PERRIGO CO | M Exercise deriv | 2011-12-29 | 2012-01-03 | 10,000 | — | $0 | 7,042 | SEC↗ |
| PRGO PERRIGO CO | S Sale | 2011-12-29 | 2012-01-03 | 10,000 | $99.05 | $990.5K | 110,912 | SEC↗ |
| PRGO PERRIGO CO | M Exercise | 2011-12-29 | 2012-01-03 | 10,000 | $17.29 | $172.9K | 120,912 | SEC↗ |
| PRGO PERRIGO CO | G Gift | 2011-12-06 | 2012-01-03 | 500 | — | $0 | 110,912 | SEC↗ |